The Prevalence of Cervical HPV Infection and Genotype Distribution in 856,535 Chinese Women with Normal and Abnormal Cervical Lesions
Journal of Cytology · 2022-10 · 39 (4) · 137-147
DOI: 10.4103/joc.joc_42_22 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cytology, 2022-10. Verfasst von Yan-Qin Yu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sc…. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Cervical cancer is the commonest cancer affecting women worldwide. During the last decades, the incidence and mortality rates of cervical cancer have increased in China. This research aims to assess the overall and genotype-specific prevalence of the human papillomavirus (HPV) infection among Chinese women with normal cervix, considering age, and geographic location. We selected studies about HPV prevalence in women from Chinese in Mainland China with normal cervix and abnormal cervical lesions, published between January 1995 and December 2020. The HPV prevalence was analyzed using meta-analysis based on the following: cytological and histological diagnoses, regions, and ages. The overall HPV prevalence in 856,535 women was 14.3%, 95% confidence interval (CI) and it increased from 8.2% to 16.5% in studies published from 2006 to 2020. The prevalence of high-risk (HR) and low-risk (LR) HPV types was 11.3% and 2.7%, respectively. The commonest types of HPV in women from Mainland China were HPV 16 (2.6%), 52 (2.4%), 58 (1.7%), 18 (0.9%), and 33 (0.8%). According to the geographical analysis, the prevalence of different HPV genotypes varied by region, Central China had the highest overall HPV prevalence. HPV16 was the commonest type in all the regions except in South China and East China, where HPV52 was found to be common. Regarding diagnosis, the HPV infection led to cervical cancer diagnosis by cytology and histology with 90.1% and 91.5% rates, respectively. HPV16 and HPV18 were common types associated with cervical cancer diagnosed by cytology and histology. HPV 16, 58, 52, 18, and 33 were the commonest types found in women with normal cervixes from Mainland China. The prevalence of different HPV genotypes varied by age group and region.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Department of Public Health and Preventive Medicine, Baotou Medical College, Baotou, Inner Mongolia, China.
- Department of Public Health and Preventive Medicine, Dalian Medical University, Dalian City, China.
- Chinese Academy of Medical Sciences and Peking Union Medical College School of Population Medicine and Public Health, Beijing, China.
Zitieren
APA
Yu, Y. Q., Hao, J. Q., Mendez, M. J. G., Mohamed, S. B., Fu, S. L., Zhao, F. H., & Qiao, Y. L. (2022). The Prevalence of Cervical HPV Infection and Genotype Distribution in 856,535 Chinese Women with Normal and Abnormal Cervical Lesions. Journal of Cytology, 39(4), 137-147. https://doi.org/10.4103/joc.joc_42_22
Vancouver
Yu YQ, Hao JQ, Mendez MJG, Mohamed SB, Fu SL, Zhao FH, et al. The Prevalence of Cervical HPV Infection and Genotype Distribution in 856,535 Chinese Women with Normal and Abnormal Cervical Lesions. Journal of Cytology. 2022;39(4):137-147. doi:10.4103/joc.joc_42_22
BibTeX
@article{Yu2022,
author = {Yu, Yan-Qin and Hao, Jin-Qi and Mendez, Maria J G and Mohamed, S Bangura and Fu, Shi-Lan and Zhao, Fang-Hui and Qiao, You-Lin},
title = {The Prevalence of Cervical HPV Infection and Genotype Distribution in 856,535 Chinese Women with Normal and Abnormal Cervical Lesions},
journal = {Journal of Cytology},
year = {2022},
volume = {39},
number = {4},
pages = {137--147},
doi = {10.4103/joc.joc_42_22}
}
EUVIMED